Congressional Dietary Supplement Caucus hosts educational nutrient briefing on Capitol Hill
WASHINGTON — An educational briefing, “Widespread Nutrient Shortfalls: A Public Health Crisis?” was held for Capitol Hill staffers Friday by the Congressional Dietary Supplement Caucus, in cooperation with the leading trade associations representing the dietary supplement industry — the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the United Natural Products Alliance.
The briefing posed the question, “What do nearly 300 million Americans have in common?” The answer, “nutrient shortfalls,” was presented by the briefing’s speaker, Victor Fulgoni, SVP Nutrition Impact. Fulgoni, who was instrumental in the approval of three nutrition health claims authorized by the Food and Drug Administration, walked the audience through data from the U.S. Government’s National Health and Nutrition Examination Survey that demonstrated how nutrient shortfalls exist for several vitamins and minerals, and why this could have a negative impact on our population’s health. He also discussed ways in which nutritional gaps could be filled.
“Government data has confirmed that our population is not getting all the key nutrients we need from food alone,” said Steve Mister, president and CEO, CRN. “We seem to be generally well-fed, but not necessarily well-nourished. Dietary supplements play the important role of filling nutrient gaps, and our industry is armed to support efforts to get our population’s nutrition to where it should be.”
“Dr. Fulgoni’s presentation underscores the need for better understanding nutritional gaps and the potential health benefits of dietary supplements,” said John Shaw, CEO NPA. “Millions of Americans find that taking supplements in accordance with their doctor’s guidance can minimize vitamin and mineral deficiencies for supporting long-term health.”
This was the fourth DSC educational briefing for the 113th Congress and the 19th briefing since the DSC was formed in 2006.
Dove Men+Care kicks off March Madness campaign
ENGLEWOOD CLIFFS, N.J. — To help guys during March Madness, Unilever’s Dove Men+Care is running throughout the 2014 NCAA Men’s Division I Basketball Championship a new campaign that will shine a spotlight on basketball’s top decision makers to show sports fans that Dove Men+Care is an easy decision for men’s grooming routines during game day and beyond, the manufacturer has announced.
The new “Easy Decision” campaign includes a video series featuring basketball decision-makers and coaches Frank Vogel and Jay Wright. As top professional and NCAA head coaches, Vogel and Wright decide team lineups and high-pressure plays almost daily. The “Easy Decision” campaign will highlight how Dove Men+Care body wash and bar offer more care for men’s skin. The videos will air throughout March Madness programming as part of Unilever’s multi-year NCAA corporate partnership with CBS Sports and Turner Sports, and on www.youtube.com/dovemencareus.
“Vogel and Wright are experienced decision-makers who have to make incredibly tough choices under pressure and while on the clock,” said Rob Candelino, VP Unilever Skincare. “Dove Men+Care has partnered with these top decision-makers to show guys everywhere that no matter what type of tough every day choices they face, choosing products with more care for your skin is an easy decision.”
Fans can visit www.DoveMenCare.com to find NCAA Basketball facts, stats and expert picks to inform the toughest bracket choices. Fans also can visit @DoveMenCare via Twitter, Instagram and Facebook to learn about leading #TournamentDecisions as they unfold in March, and share their own for a chance to win prizes.
In 2014, Dove®Men+Care introduced the new Expert Shave range in collaboration with barbers and dermatologists. New Aqua Impact Shampoo, formulated to make men’s hair three times stronger, and Fresh Awake Deodorant and Antiperspirant, designed to be tough on sweat, not on skin, also joined the existing lines of Dove®Men+Care personal washes, antiperspirants and deodorants, face products and hair care.
Pierre Fabre Dermatologies approved to market Hemangeol
CASTRES, France and PARSIPPANY, N.J. — Pierre Fabre Dermatologies announced that it received authorization from the Food and Drug Administration to market the pediatric drug Hemangeol (propranolol hydrochloride).
It is the first and only approved treatment for “proliferating infantile hemangioma requiring systemic therapy," the company said. Infantile hemangioma is a vascular benign tumor that affects 3% to 10% of newborns.
“This collaboration has endowed pediatric dermatology with a new therapy that fulfills an unmet medical need and thousands of American children may now benefit from this new therapy each year,” said Dr. Jean-Jacques Voisard, dermatologist, general manager of Pierre Fabre Dermatologie.
Hemangeol will be available in June 2014.